- NEWS
Long-COVID research just got a big funding boost: will it find new treatments?
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$32.99 / 30 days
cancel any time
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Nature 648, 502-503 (2025)
doi: https://doi.org/10.1038/d41586-025-03904-w
References
Diexer, S. et al. Sci. Rep. 15, 25830 (2025).
Kim, D. Commun. Med. 5, 104 (2025).
Bansal, A. npj Prim. Care Respir. Med. 35, 53 (2025).
Venkatesan, P. Lancet Microbe 6, 101166 (2025).
Long COVID activists fought Trump team’s research cuts and won ― for now
Four years on: the career costs for scientists battling long COVID
Long COVID still has no cure — so these patients are turning to research
A reboot for chronic fatigue syndrome research
Long-COVID signatures identified in huge analysis of blood proteins
What causes long COVID? Case builds for rogue antibodies
Long COVID is a double curse in low-income nations — here’s why